CAD and Multiple Risk Factors
CAD and Multiple Risk Factors is organized by Paradigm Medical Communications, LLC.
Release Date: April 28, 2023
Expiration Date: April 28, 2024
Program Overview:
Patients with CAD often have multiple risk factors that make them vulnerable to secondary cardiovascular events. Therefore, ongoing treatment must provide adequate protection. Join our expert faculty as they discuss the latest evidence informing the optimal treatment of patients with CAD and multiple risk factors using a real-life interactive case study.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Outline key clinical trial data related to the use of dual pathway inhibition (DPI) in the treatment of CAD and/or PAD
Develop CAD and/or PAD treatment plans that demonstrate appropriate use of DPI in heterogeneous patients